Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPRM1 Genotype Effect on Morphine Response
NCT01878006Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Jun 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of morphine in pain, sponsored by National Institute on Alcohol Abuse and Alcoholism. Started Jun 2013; status: completed.
02
Drugs
morphine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01878006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878006.